Exact Mass: 244.0253
Exact Mass Matches: 244.0253
Found 97 metabolites which its exact mass value is equals to given mass value 244.0253,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Fucose 1-phosphate
Fucose 1-phosphate (CAS: 16562-58-6) belongs to the class of organic compounds known as monosaccharide phosphates. These are monosaccharides comprising a phosphate group linked to the carbohydrate unit. Fucose 1-phosphate is an intermediate in the reversible synthesis of GDP-L-fucose catalyzed by the enzyme guanosine triphosphate fucose pyrophosphorylase (GFPP, EC 2.7.7.30). The reversible reaction is magnesium-dependent, although the enzyme is partially active when cobalt or manganese is substituted. The reaction is unusual in that, of the four canonical nucleoside triphosphates, only guanosine can be utilized efficiently to form a nucleotide-sugar. Free cytosolic fucose is phosphorylated by L-fucokinase (EC 2.7.1.52) to form fucose-1-phosphate in the salvage pathway of GDP-L-fucose (PMID: 16185085, 14686921). Fucose-1-phosphate is an intermediate in the reversible synthesis of GDP-L-fucose, in a reaction catalyzed by the enzyme guanosine triphosphate fucose pyrophosphorylase (GFPP, E.C. 2.7.7.30) . The reversible reaction is magnesium-dependent, although the enzyme is partially active when cobalt or manganese is substituted. The reaction is unusual in that, of the four canonical nucleoside triphosphates, only guanosine can be utilized efficiently to form a nucleotide-sugar. Free cytosolic fucose is phosphorylated by L-fucokinase (EC 2.7.1.52) to form fucose-1-phosphate in the salvage pathway of GDP-L-fucose. (PMID: 16185085, 14686921) [HMDB]
Apraclonidine
Apraclonidine is only found in individuals that have used or taken this drug.Apraclonidine, also known as iopidine, is a sympathomimetic used in glaucoma therapy.Apraclonidine is a relatively selective alpha2 adrenergic receptor agonist that stimulates alpha1 receptors to a lesser extent. It has a peak ocular hypotensive effect occurring at two hours post-dosing. The exact mechanism of action is unknown, but fluorophotometric studies in animals and humans suggest that Apraclonidine has a dual mechanism of action by reducing aqueous humor production through the constriction of afferent ciliary process vessels, and increasing uveoscleral outflow. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
L-Rhamnulose 1-phosphate
A deoxyketohexose phosphate consisting of L-rhamnulose having a monophosphate group at the 1-position.
2-Deoxy-D-arabino-hexose 6-(dihydrogen phosphate)
alpha-L-(-)-Fucose 1-phosphate bis(cyclohexylammonium) salt
N-((5-bromopyridin-3-yl)methyl)-2-methoxyethanamine
3-AMINO-3-(5-CHLORO-2-NITRO-PHENYL)-PROPIONIC ACID
METHYL 4-ACETYL-3-METHYL-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLATE
2-thiophen-3-yl-3H-benzimidazole-5-carboxylic acid
2-THIOPHEN-2-YL-3H-BENZOIMIDAZOLE-4-CARBOXYLIC ACID
2-THIOPHEN-2-YL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
5-(1H-BENZOIMIDAZOL-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE
N-(5-bromo-2-pyrimidinyl)-N,N-dimethylethane-1,2-diamine
Benzenemethanol, alpha,alpha-bis(trifluoromethyl)-
(3-(3-CHLOROPHENYL)ISOXAZOL-5-YL)METHANAMINE HYDROCHLORIDE
Imidazo[1,2-a]pyridine-7-carboxylic acid, 2-(2-thienyl)
1-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-3,5-DIMETHYL-1H-PYRAZOLE HYDROBROMIDE
poassium 3-methoxyethylether phenyl trifluoroborate
(2-Chloro-4-methoxy-5-(methoxycarbonyl)phenyl)boronic acid
3-AMINO-3-(4-CHLORO-3-NITRO-PHENYL)-PROPIONIC ACID
Methyl 7-(trifluoromethyl)-1-benzofuran-2-carboxylate
2-{[(2-chloro-6-fluorophenyl)methyl]sulfanyl}-4,5-dihydro-1H-imidazole
[(3S,4R,5S)-3,4,5-trihydroxy-2-keto-hexyl] dihydrogen phosphate
[(2S,4S,5S)-4-hydroxy-5-(methylsulfanylmethyl)oxolan-2-yl] dihydrogen phosphate
[(2S,3S,4S,5S)-3,4,5,6-tetrahydroxyoxan-2-yl]methanesulfonic acid
[(2S,3S,4S,5S,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methanesulfonic acid
apraclonidine
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
6-deoxy-6-sulfo-D-fructofuranose
A carbohydrate sulfonate that is D-fructofuranose in which the hydroxy group at at position 6 is replaced by a sulfo group.
2-Deoxy-D-glucose 6-phosphate
A deoxyaldohexose phosphate comprising 2-deoxy-D-glucose having the phosphate group at the 6-position.
6-sulfo-beta-D-quinovose
A 6-sulfo-D-quinovose (6-deoxy-6-sulfo-D-glucopyranose) that has beta configuration at the anomeric centre.
6-sulfo-alpha-D-quinovose
A 6-sulfo-D-quinovose that has alpha configuration at the anomeric centre.
6-Sulfo-d-quinovose
A carbohydrate sulfonate that is D-quinovose (6-deoxy-D-glucose) in which one of the methyl hydrogens at position 6 is replaced by a sulfo group.
